Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519337 · ClinicalTrials.gov registry record · Phase 4
Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation
A Phase 4 study of Inflammation and Cardiac Surgery, sponsored by Hartford Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00519337: Completed Phase 4 study of Inflammation and Cardiac Surgery, sponsored by Hartford Hospital.
NCT00519337 is a Phase 4 study of Inflammation and Cardiac Surgery that has completed, run by Hartford Hospital. The registered enrollment target is 25 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519337, a Phase 4 study of Inflammation and Cardiac Surgery, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Ascorbic acid
Study Locations (1)
Connecticut
- Hartford Hosptial - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-04 |
| Phase | Phase 4 |
What the finished NCT00519337 record still lists
NCT00519337 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00519337 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00519337 about?
NCT00519337 is a clinical study titled "Impact of Ascorbic Acid on Post-Cardiothoracic Surgery Inflammation". The purpose of this study is to see if ascorbic acid (Vitamin-C) therapy will reduce inflammation following heart surgery.
What is the current status of trial NCT00519337?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2008-10. Estimated completion is 2011-04.
What conditions does trial NCT00519337 study?
This clinical trial studies the following conditions: Inflammation, Cardiac Surgery.
What interventions are being tested in trial NCT00519337?
The interventions under investigation include: Placebo (DRUG), Ascorbic acid (DRUG).
Who is sponsoring clinical trial NCT00519337?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00519337 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00519337's enrollment target sits among peer trials
25 113th of 132 higher than 17 of 132 other Inflammation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Skin Barrier Function and Inflammation in Aging: The BIA Study
RECRUITING · Phase 4
-
Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
COMPLETED · Phase 4
-
Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes
COMPLETED · Phase 4
-
Efficacy of Ketorolac 0.4% in Prostaglandin Suppression
COMPLETED · Phase 4
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia